Provided by Tiger Fintech (Singapore) Pte. Ltd.

RECCE PHARMACEUTICALS LTD

0.305
-0.015-4.69%
Volume:532.26K
Turnover:163.93K
Market Cap:79.91M
PE:-3.32
High:0.345
Open:0.345
Low:0.295
Close:0.320
Loading ...

Company Profile

Company Name:
RECCE PHARMACEUTICALS LTD
Exchange:
ASX
Establishment Date:
2007
Employees:
- -
Office Location:
Salesforce Tower,Level 23,180 George Street,Sydney,New South Wales,Australia
Zip Code:
2000
Fax:
- -
Introduction:
Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of antibiotics in Australia and the United States. Its lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.